HOME >> 海外出版社刊 洋書販売 新着書籍 >>

Canine Endocrinology

表紙見本写真

Edra Publishing US LLC

EditorSara Galac / Federico Fracassi

特価:19,580円 (本体 17,800円+税) 送料サービス

・Release: 2024

・ISBN: 9781957260457

・336 Pages

・Trim Size: 220.0 x 25.0 x 280.0 ・Hardcover

Description

In the fascinating world of endocrinology, scientific knowledge and technology have advanced greatly in recent years. Alongside, the ability to diagnose, treat, and manage various endocrine disorders has progressed too. The goal of this textbook is to provide an up-to-date, comprehensive, yet accessible resource for understanding and managing endocrine disorders in dogs. The book is divided into two parts. The first part adopts a problem-oriented approach to the most common clinical and laboratory abnormalities in dogs with endocrine diseases. This section, full algorithms that guide step by step veterinarians in diagnostic evaluation and setting up the treatment, serves as a quick reference guide in clinical situations. The second part focuses on endocrine diseases. Each chapter starts with the basic anatomy and physiology of the specific endocrine glands, followed by detailed discussions on clinical signs, diagnostic methodologies, and management strategies. Chapters are richly supplemented with videos available through QR codes, boxes, tables, algorithms, charts, imaging studies, and illustrations.

Table of Contents

  • Cover
  • Title
  • Copyright
  • Series editors
  • Book editor
  • Contributors
  • Series preface
  • Preface
  • Abbreviations
  • Table of contents
  • SECTION I Differential diagnoses for owner chief concerns and physical examination findings
  • Chapter 1 Growth retardation
  • Pathophysiology
  • Diagnostic approach
  • Chapter 2 Alopecia
  • Pathophysiology
  • Classification and clinical signs
  • Diagnostic approach
  • Chapter 3 Weight loss
  • Pathophysiology
  • Clinical signs
  • Diagnostic approach
  • Chapter 4 Polyuria and polydipsia
  • Physiology and pathophysiology
  • Definitions and initial considerations
  • Signalment, history, physical examination
  • Diagnostic approach
  • Diagnosis
  • Chapter 5 Polyphagia
  • Pathophysiology
  • Diagnostic approach
  • Chapter 6 Exercise intolerance
  • Pathophysiology
  • Clinical signs
  • Diagnostic approach
  • Chapter 7 Obesity
  • Etiology and pathophysiology
  • Clinical signs
  • Diagnostic approach
  • Therapy
  • Prevention of obesity
  • Chapter 8 Hypertension
  • Pathophysiology
  • Clinical signs
  • Diagnostic approach
  • Diagnosis
  • Considerations for treatment
  • SECTION II Differential diagnoses for clinicopathologic abnormalities
  • Chapter 9 Hyperglycemia
  • Pathophysiology
  • Clinical signs
  • Diagnostic approach
  • Chapter 10 Hypoglycemia
  • Pathophysiology
  • Clinical signs
  • Diagnostic approach
  • Chapter 11 Low thyroxine
  • Pathophysiology
  • Clinical signs
  • Diagnostic approach
  • Chapter 12 Hyperlipidemia
  • Pathophysiology
  • Clinical signs
  • Diagnostic approach
  • Diagnosis
  • Treatment
  • Chapter 13 Hyperkalemia
  • Pathophysiology
  • Clinical signs
  • Diagnostic approach
  • Chapter 14 Hypokalemia
  • Pathophysiology
  • Clinical signs
  • Diagnostic approach
  • Chapter 15 Hypernatremia
  • Pathophysiology
  • Clinical signs
  • Diagnostic approach
  • Chapter 16 Hyponatremia
  • Pathophysiology
  • Clinical signs
  • Diagnosis
  • Chapter 17 Hypocalcemia
  • Pathophysiology
  • Clinical signs
  • Diagnostic approach
  • Chapter 18 Hypercalcemia
  • Pathophysiology
  • Clinical signs
  • Diagnostic approach
  • Diagnosis
  • Therapy
  • Chapter 19 Proteinuria
  • Pathophysiology
  • Clinical signs
  • Diagnostic approach
  • Treatment
  • SECTION III Techniques and procedures
  • Chapter 20 Blood pressure measurements
  • Blood pressure measurement techniques
  • Indications for blood pressure measurement
  • Chapter 21 Glucose monitoring
  • Measurement of blood glucose using automated chemistry analyzers
  • Use of portable blood glucose meter devices
  • Continuous glucose monitoring systems
  • Flash glucose monitoring systems
  • New technologies
  • Chapter 22 Hormone measurements
  • Types of assays
  • Binding proteins and free hormone measurement
  • Validation, verification, and quality
  • Transferability of results
  • SECTION IV Endocrinologic diseases
  • Chapter 23 Hypothalamus and pituitary gland: anatomy and physiology
  • Anatomy
  • Physiology
  • Chapter 24 Growth hormone disorders
  • Physiologic effect
  • Hypersomatotropism (acromegaly)
  • Pituitary dwarfism
  • Chapter 25 Vasopressin-related disorders of water homeostasis
  • Syndrome of inappropriate ADH release
  • Diabetes insipidus
  • Primary polydipsia
  • Primary adipsia
  • Chapter 26 Anatomy and physiology of the thyroid gland
  • Anatomy
  • Physiology
  • Chapter 27 Canine hypothyroidism
  • Etiology
  • Clinical features
  • Endocrine testing
  • Diagnostic imaging
  • Treatment
  • Prognosis
  • Chapter 28 Thyroid tumors and hyperthyroidism
  • Etiology
  • Clinical features
  • Diagnostic imaging
  • Diagnosis
  • Therapy
  • Prognosis
  • Chapter 29 Anatomy and physiology of parathyroid glands and calcium metabolism
  • Anatomy of the canine parathyroid glands
  • Parathyroid physiology and its role in calcium homeostasis
  • Chapter 30 Primary hyperparathyroidism.
  • Etiology
  • Clinical features
  • Clinicopathological findings
  • Endocrine tests
  • Diagnostic imaging
  • Diagnosis
  • Therapy
  • Post-treatment management
  • Histopathology
  • Prognosis
  • Parathyroids and concurrent endocrine diseases
  • Chapter 31 Hypoparathyroidism: naturally occurring and iatrogenic
  • Pathogenesis of PTH deficiency
  • Signalment of animals with hypoparathyroidism
  • History and clinical manifestation of hypoparathyroidism
  • Diagnostic procedures and endocrine testing
  • Treatment
  • Does hungry bone syndrome exist in dogs?
  • Acute management of symptomatic hypocalcemia
  • Concurrent conditions complicating the management of primary idiopathic hypoparathyroidism
  • Long-term treatment and prognosis
  • Chapter 32 Anatomy and physiology of the adrenal glands
  • Anatomy
  • Physiology
  • Chapter 33 Hypoadrenocorticism
  • Etiology
  • Clinical features
  • Clinicopathological findings
  • Endocrine testing
  • Diagnostic imaging
  • Treatment
  • Prognosis
  • Chapter 34 Cushing’s syndrome.
  • Pathogenesis and clinical manifestations
  • Pathogenesis
  • Epidemiology
  • Clinical features
  • Clinicopathological findings
  • Endocrine testing
  • Low-dose dexamethasone suppression test
  • Urinary cortisol-to-creatinine ratio
  • ACTH stimulation test
  • Endogenous ACTH
  • High-dose dexamethasone suppression test
  • Diagnostic imaging
  • Abdominal ultrasonography
  • Computed tomography
  • Magnetic resonance imaging
  • General treatment considerations
  • Medical treatment
  • Adrenal-directed drugs (traditional options)
  • Adrenal-directed drugs (future options)
  • Pituitary-directed drugs
  • Surgical treatment: trans-sphenoidal hypophysectomy
  • Preoperative evaluation
  • Surgical anatomy and diagnostic imaging
  • Preoperative management and surgical technique
  • Postoperative care
  • Prognosis
  • Surgical treatment: adrenalectomy
  • Surgical anatomy and disease staging
  • Complications and perioperative measures
  • Surgical approach
  • Outcome and prognosis
  • Radiation therapy
  • Types of radiation therapy
  • Treatment considerations
  • Radiation-associated toxicity
  • Outcomes of pituitary radiotherapy
  • Chapter 35 Adrenal tumors (all but cortisol-secreting and pheochromocytoma)
  • Hyperaldosteronism
  • Steroid precursors and sex hormone-secreting adrenal tumors
  • Adrenal incidentaloma: hormonally silent adrenal tumors
  • Chapter 36 Pheochromocytoma
  • Etiology
  • Clinical features
  • Clinicopathological findings
  • Diagnostic imaging
  • Diagnosis
  • Therapy
  • Prognosis
  • Chapter 37 Anatomy and physiology of the canine endocrine pancreas
  • Anatomy of the canine pancreas
  • Endocrine cell types
  • Function of islet hormones
  • Secretory control of islet hormones
  • Chapter 38 Diabetes mellitus
  • Pathogenesis, clinical manifestations, and diagnosis
  • Pathogenesis
  • Clinical manifestations
  • Diagnosis
  • General treatment considerations
  • The importance of the owner and therapeutic goals
  • Initiating insulin therapy
  • Owner education
  • Dietary recommendations
  • Exercise
  • Insulin therapy and other treatment options
  • Goals of therapy for the individual patient
  • Choosing the best insulin
  • The ultimate goal of insulin therapy: mimic physiologic insulin delivery
  • Insulin pharmacology in dogs
  • Guidelines for starting insulin therapy and adjusting the dose
  • Compliance, adherence, convenience, and cost
  • Syringe versus pen administration
  • Managing inappetence and gastrointestinal signs
  • Dietary management of diabetes
  • Recommendations regarding diet choice
  • Management of postprandial hyperglycemia in diabetic dogs
  • Monitoring a diabetic patient
  • Clinical signs
  • Blood glucose monitoring
  • Continuous glucose monitoring systems
  • Urine glucose measurement
  • Glycated proteins
  • The unstable diabetic
  • Management factors
  • Causes of insulin resistance
  • Investigation of diabetic instability
  • Long-term complications and prognosis
  • Ophthalmic long-term complications
  • Neurological long-term complications
  • Systemic hypertension and diabetic cardiomyopathy
  • Diabetic nephropathy
  • Gastrointestinal complications
  • Lipodystrophy
  • Prognosis
  • Diabetic ketosis, diabetic ketoacidosis and the hyperosmolar hyperglycemic state
  • Etiology
  • Clinical features
  • Diagnosis
  • Therapy and prognosis for diabetic ketoacidosis
  • Therapy and prognosis for hyperosmolar hyperglycemic state
  • Chapter 39 Insulinoma
  • Pathogenesis and clinical manifestations
  • Signalment
  • Clinical signs
  • Diagnostic procedures
  • Clinicopathological findings
  • Endocrine testing
  • Diagnostic imaging
  • Treatment
  • Prognosis